OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Piotrowska on Eligibility Criteria for Osimertinib in Lung Cancer Treatment

February 29th 2020

Zofia Piotrowska, MD, MHS, discusses the patient populations eligible to receive osimertinib as treatment for lung cancer.

Dr. Ramakrishnan on Updates in DLBCL

February 29th 2020

Praveen Ramakrishnan, MD, assistant professor, Department of Internal Medicine, UT Southwestern Medical Center, discusses updates in diffuse large B-cell lymphoma (DLBCL) that were presented at the 2019 ASH Annual Meeting.

Dr. Heyman on the Use of Maintenance Rituximab in Follicular Lymphoma

February 29th 2020

Benjamin Heyman, MD, assistant clinical professor of medicine, University of California, San Diego, discusses the use of maintenance rituximab (Rituxan) in patients with follicular lymphoma.

Dr. McGregor on Combos With Nivolumab, Cabozantinib, and Sunitinib in RCC

February 29th 2020

Bradley McGregor, MD, discusses combination therapies with nivolumab, cabozantinib, and sunitinib in renal cell carcinoma.

Dr. Powles on the Mission of the Uromigos Twitter Group

February 29th 2020

Thomas Powles, MD, MBBS, MRCP, discusses the mission and goals for the Uromigos Twitter group.

Dr. Tzachanis on Data With Lisocabtagene Maraleucel in Lymphoma

February 28th 2020

Dimitrios Tzachanis, MD, PhD, discusses data with lisocabtagene maraleucel (liso-cel) in large B-cell lymphoma, as well as the differences between axicabtagene ciloleucel (axi-cel; Yescarta) and tisagenlecleucel (Kymriah).

Dr. Liebman on the Use of Digital Surveillance in Melanoma

February 28th 2020

Tracey Liebman, MD, discusses the use of digital surveillance in melanoma.

Dr. Lazarides on Research Regarding Margin Assessment in Sarcoma

February 28th 2020

Alexander Leandros Lazarides, MD, discusses research regarding margin assessment in patients with sarcoma.

Dr. Chae on Using Crizotinib to Treat MET+ NSCLC

February 28th 2020

Young Kwang Chae, MD, MPH, MBA, discusses using crizotinib to treat MET-positive patients with non–small cell lung cancer.

Dr. Schroeder on Treatment Options for GVHD

February 28th 2020

Mark A. Schroeder, MD, discusses therapies currently available and being investigated to treat patients with graft-versus-host disease.

Dr. Reckamp on Targeted Therapy Options for Rare Mutations in NSCLC

February 28th 2020

Karen L. Reckamp, MD, MS, discusses targeted therapy options for rare mutations in non–small cell lung cancer.

Dr. Goodman on Contributing Factors to the Lack of Development in PTCL Treatment

February 28th 2020

Aaron Goodman, MD, discusses factors that have contributed to the lack of treatment development in peripheral T-cell lymphoma.

Adding CAR T-Cell Therapy to the Electronic Medical Record

February 28th 2020

Andrea Price, APN, discusses adding CAR T-cell therapy to the electronic medical record.

Dr. Joshi on Durvalumab/RT Combo in Locally Advanced Urothelial Cancer

February 28th 2020

Monika Joshi, MD, discusses durvalumab (Imfinzi) and radiation therapy (DUART) in locally advanced urothelial cancer of the bladder.

Dr. Shapiro on the Surgical Management of Advanced-Stage Melanoma

February 28th 2020

Richard L. Shapiro, MD, discusses the surgical management of advanced-stage melanoma.

Dr. Gibbs on the Lack of Treatment Options in Sarcoma

February 27th 2020

C. Parker Gibbs Jr, MD, discusses the lack of treatment options for patients with soft tissue and bone sarcomas.

Dr. Rossetti on Symptom Management for MPNs

February 27th 2020

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

Dr. Pemmaraju on Methods to Treat Anemia in MPNs

February 27th 2020

Naveen Pemmaraju, MD, discusses methods to address anemia in patients with myelodysplastic syndromes.

Dr. Kremyanskaya on Unmet Needs in Myelofibrosis

February 27th 2020

Marina Kremyanskaya, MD, PhD, discusses unmet needs in myelofibrosis.

Dr. McKay on a Real-World Analysis of Radium-223 in mCRPC

February 27th 2020

Rana R. McKay, MD, discusses the results of a real-world analysis of radium-223 in patients with metastatic castration-resistant prostate cancer.